Valeant hepatitis C drug misses goal, shares dive (Hep C Treatment)

Valeant hepatitis C drug misses goal, shares dive
Reuters - Mar 21, 2006... Valeant Pharmaceuticals International (VRX.N: Quote, Profile, Research) said on Tuesday a late-stage trial showed its chronic hepatitis C treatment was not as ...

Chronic hepatitis C treatment may be aided by thalidomide
Therapeutics Daily (subscription) (press release), PA - Mar 27, 20062006 MAR 27 - (NewsRx.com) -- Research from Italy has reported that thalidomide aids in the treatment of chronic hepatitis C unresponsive to alfa-interferon ...

Novartis Announces in-licensing of Valopicitabine (NM283), a Novel ...
PharmaLive.com (press release), PA - Mar 29, 2006... synergistic with valopicitabine, and this combination could become the first oral combination therapy available for the treatment of chronic hepatitis C. ...

Novelos Therapeutics Closes $15 Million Private Placement
International News Service, Australia - Mar 7, 2006... NOV-002 in lung cancer, in addition to our other clinical development programs, including chemotherapy-resistant ovarian cancer and chronic hepatitis C with NOV ...